Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of tucidinostat in Japanese patients with cancer
jRCT2080223600Phase 2Completed
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tucidinostat in cancer. Started Jul 2017; status: completed.
02
Drugs
tucidinostat
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223600.